
News|Podcasts|June 27, 2025
Allen's Story: The Promising Potential of Intratumoral Immunotherapy
Author(s)Alexandra Gerlach, Content Producer
Advertisement
Allen Rappert, a St. Louis resident diagnosed with stage four squamous cell carcinoma, found hope through Dr. Jason Williams' intratumoral immunotherapy at the Williams Cancer Institute. Despite a grim prognosis, Allen's tumor was targeted directly, leading to his cancer-free status. Dr. Williams helped develop this treatment approach, which involves injecting immunotherapy drugs directly into tumors. Allen's case highlights the effectiveness of this method, which has a high success rate. Dr. Williams emphasizes the need for early treatment and shares his vision for future cancer care, advocating for immediate treatment at the time of biopsy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
3
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
4
Darovasertib Plus Crizotinib Shows Striking Efficacy in HLA-A2–Negative Metastatic Uveal Melanoma, OptimUM-02 Results Show
5








































































































































